Randy Yeh

16PUBLICATIONS
128CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCell physiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 13, 2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.

|Jun 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer.

|Sep 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract Cancer.

Darren Cowzer, Madison Darmofal, Kenneth Seier

|Dec 06, 2022
Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.

Laurent Dercle, Shawn Sun, Romain-David Seban

|Nov 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.

Justin Jee, Emily S Lebow, Randy Yeh

Pageof 3